FI882746A0 - Hybridprotein c och foerfarande foer dess framstaellning. - Google Patents

Hybridprotein c och foerfarande foer dess framstaellning.

Info

Publication number
FI882746A0
FI882746A0 FI882746A FI882746A FI882746A0 FI 882746 A0 FI882746 A0 FI 882746A0 FI 882746 A FI882746 A FI 882746A FI 882746 A FI882746 A FI 882746A FI 882746 A0 FI882746 A0 FI 882746A0
Authority
FI
Finland
Prior art keywords
hybrid protein
foerfarande foer
och foerfarande
foer dess
dess framstaellning
Prior art date
Application number
FI882746A
Other languages
English (en)
Other versions
FI882746A (fi
Inventor
Wakako Iwasaki
Mikiko Takahashi
Tamotsu Hashimoto
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of FI882746A0 publication Critical patent/FI882746A0/fi
Publication of FI882746A publication Critical patent/FI882746A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI882746A 1987-06-12 1988-06-09 Hybridprotein c och foerfarande foer dess framstaellning. FI882746A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14529387 1987-06-12

Publications (2)

Publication Number Publication Date
FI882746A0 true FI882746A0 (fi) 1988-06-09
FI882746A FI882746A (fi) 1988-12-13

Family

ID=15381791

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882746A FI882746A (fi) 1987-06-12 1988-06-09 Hybridprotein c och foerfarande foer dess framstaellning.

Country Status (7)

Country Link
EP (1) EP0296413A2 (fi)
JP (1) JP2799316B2 (fi)
KR (1) KR890000517A (fi)
AU (1) AU1756588A (fi)
DK (1) DK317288A (fi)
FI (1) FI882746A (fi)
PT (1) PT87688B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516650A (en) * 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
JP2728240B2 (ja) * 1988-07-26 1998-03-18 ヘキスト薬品工業株式会社 ヒトプロテインｃ変異体及びその製造方法
US5298599A (en) * 1988-12-30 1994-03-29 Oklahoma Medical Research Foundation Expression and purification of recombinant soluble tissue factor
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
JP3153236B2 (ja) * 1989-12-22 2001-04-03 ザイモジェネティクス，インコーポレイティド 端が切り取られた軽鎖を有する組換えプロテインｃ
AU7168591A (en) * 1989-12-29 1991-07-24 Zymogenetics Inc. Hybrid protein c
US5225537A (en) * 1989-12-29 1993-07-06 Zymogenetics, Inc. Methods for producing hybrid phospholipid-binding proteins
EP0521873B1 (en) * 1990-01-29 1999-06-02 Zymogenetics, Inc. Anticoagulant proteins
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
ATE321846T1 (de) * 1996-11-08 2006-04-15 Oklahoma Med Res Found Verwendung eines modifizierten protein-c
US6017882A (en) * 1997-10-23 2000-01-25 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6693075B1 (en) 1997-10-23 2004-02-17 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7247708B2 (en) 1997-10-23 2007-07-24 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6747003B1 (en) 1997-10-23 2004-06-08 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6998122B1 (en) 1999-04-30 2006-02-14 Eli Lilly And Company Protein C derivatives
DE60108076T2 (de) 2000-02-02 2006-03-16 Eli Lilly And Co., Indianapolis Protein c derivate
WO2001059084A1 (en) 2000-02-11 2001-08-16 Eli Lilly And Company Protein c derivatives
PL206148B1 (pl) 2000-02-11 2010-07-30 Bayer HealthCare LLCBayer HealthCare LLC Koniugat polipeptydowy, polipeptyd, sekwencja nukleotydowa, wektor ekspresyjny, komórka gospodarz, sposób wytwarzania koniugatu polipeptydowego, środek farmaceutyczny i zastosowanie koniugatu polipeptydowego
US7220837B1 (en) 2000-04-28 2007-05-22 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7812132B2 (en) 2000-04-28 2010-10-12 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US20030211094A1 (en) 2001-06-26 2003-11-13 Nelsestuen Gary L. High molecular weight derivatives of vitamin k-dependent polypeptides
CN1665925A (zh) 2002-04-30 2005-09-07 马克西根控股公司 凝血因子Ⅶ或Ⅶa多肽变体
US7771996B2 (en) 2003-03-20 2010-08-10 Bayer Healthcare Llc FVII or FVIIa variants
BRPI0411650A (pt) 2003-06-19 2006-08-08 Maxygen Holdings Ltd variante polipeptìdica do fator vii (fvii) ou do fator viia (fviia), sequencia de nucleotìdeos , vetor de expressão, célula hospedeira, composição, uso de uma variante, e, método para tratar de um mamìfero tendo uma doença ou um distúrbio em que a formação de coágulo seja desejável

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
ATE93272T1 (de) * 1985-06-27 1993-09-15 Zymogenetics Inc Expression von protein c.
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C

Also Published As

Publication number Publication date
EP0296413A2 (en) 1988-12-28
DK317288A (da) 1988-12-13
KR890000517A (ko) 1989-03-15
JPS6485096A (en) 1989-03-30
FI882746A (fi) 1988-12-13
PT87688A (pt) 1988-07-01
JP2799316B2 (ja) 1998-09-17
DK317288D0 (da) 1988-06-10
AU1756588A (en) 1988-12-15
PT87688B (pt) 1992-09-30

Similar Documents

Publication Publication Date Title
FI883436A0 (fi) Vaetskebehaollare och dess framstaellningsfoerfarande.
FI900976A0 (fi) Huvudbonad och foerfarande foer dess framstaellning.
FI880216A0 (fi) I vaexter verksam fosfinotricinresistensgen och dess anvaendning.
FI882746A (fi) Hybridprotein c och foerfarande foer dess framstaellning.
FI885148A0 (fi) Siktkorg och foerfarande foer dess tillverkning.
FI881372A (fi) Katalytunderlag och foerfarande foer dess framstaellning.
FI900709A0 (fi) Taendsystem och foerfarande foer dess taendning.
FI884318A0 (fi) Imidazopyridinfoerening och foerfarande foer dess framstaellning.
FI884256A0 (fi) Livsmedelsfoerpackning och foerfarande foer dess framstaellning.
FI880453A0 (fi) Narkosmedelkomposition och foerfarande foer dess anvaendning.
FI893269A (fi) Sprickor detekterande glasskiva och foerfarande foer dess framstaellning.
FI881339A0 (fi) Kompaktlysroer och foerfarande foer dess framstaellning.
FI880543A0 (fi) Lyftstropp och foerfarande foer dess framstaellning.
FI873285A0 (fi) Fiberarmerat roerelement och foerfarande foer dess tillverkning.
FI884004A (fi) Benzofuranderivat och foerfarande foer dess framstaellning.
FI880875A (fi) Haorkosmetisk sammansaettning och dess framstaellningsfoerfarande.
FI870761A (fi) Filmaggregat och foerfarande foer dess framstaellning.
FI872837A (fi) Skivmaterial och foerfarande foer dess framstaellning.
FI870757A0 (fi) Lyftstropp och foerfarande foer dess tillverkning.
FI884320A0 (fi) Jaestextrakt och foerfarande foer dess framstaellning.
FI871622A0 (fi) Byggnadselement och dess kantprofil.
FI873286A (fi) Fiberarmerat plastroer och foerfarande foer dess tillverkning.
FI874052A0 (fi) Tryckalster och dess avsaendningsfoerfarande.
FI875709A0 (fi) Saorfoerband och dess framstaellning.
FI872486A0 (fi) Skarvfog foer paolar och foerfarande foer dess framstaellning.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HOECHST JAPAN LIMITED